DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Reviewed by the HealthVetted Editorial
Obstructive sleep apnea (OSA) is a common, treatable sleep disorder in which the muscles around the throat relax and the upper airway repeatedly narrows or collapses during sleep, briefly blocking breathing dozens or even hundreds of times a night. Each pause lowers blood oxygen and jolts the brain partly awake to reopen the airway, so sleep is fragmented even when a person believes they slept through the night — and over time the condition is closely tied to daytime sleepiness, high blood pressure, and heart disease.
During normal sleep, the muscles of the throat relax but the upper airway stays open enough to breathe freely. In OSA, the soft tissues at the back of the throat — the soft palate, uvula, tongue base, and walls of the pharynx — relax too much and the airway narrows or closes. A complete blockage lasting at least 10 seconds is called an apnea; a partial blockage that reduces airflow and is accompanied by an oxygen drop or a brief awakening (arousal) is called a hypopnea (NIH/StatPearls; American Academy of Sleep Medicine, AASM).
Each event causes a fall in blood oxygen and a surge of effort to breathe against the closed airway. The brain responds with a brief arousal that reopens the airway, often with a gasp, snort, or choke — and then the cycle repeats. Because these arousals are usually too short to be remembered, many people have no idea their sleep is being interrupted; the chief clue is often a bed partner reporting loud snoring and pauses in breathing.
OSA is the most common form of sleep-disordered breathing. Its medical name is obstructive sleep apnea, and the ICD-10 code most often used is G47.33 (obstructive sleep apnea). It is distinct from central sleep apnea, in which the brain intermittently fails to signal the breathing muscles (so there is no airway obstruction and often no snoring); some people have a mix of both, called complex or mixed sleep apnea.
OSA is widespread. Population studies estimate that a substantial share of middle-aged and older adults have at least mild OSA, and prevalence is markedly higher in men, in people with obesity, and with advancing age (NIH/StatPearls). Many cases remain undiagnosed because the symptoms develop gradually and overlap with ordinary fatigue.
OSA is fundamentally an anatomical and neuromuscular problem: the airway is either structurally smaller, more prone to collapse, or insufficiently supported by muscle tone during sleep. Several factors push the airway toward collapse:
Well-established risk factors recognized across sleep-medicine guidelines include (NIH/StatPearls; AASM):
OSA is also bidirectionally linked with cardiovascular and metabolic disease: it is highly prevalent among people with resistant hypertension, atrial fibrillation, heart failure, stroke, and type 2 diabetes, and it can worsen these conditions in turn (American Heart Association scientific statement on OSA and cardiovascular disease, *Circulation*).
Symptoms span both the night and the day, and a bed partner often notices the nighttime signs first.
Nighttime symptoms:
Daytime symptoms:
It is important to know that not everyone with OSA snores loudly, and many people — especially women — present with less classic symptoms such as fatigue, insomnia, anxiety, or depression rather than obvious sleepiness. This is one reason OSA is under-recognized in women.
Diagnosis begins with a clinical evaluation of symptoms and risk factors, often aided by validated questionnaires such as STOP-Bang (snoring, tiredness, observed apneas, blood pressure, BMI, age, neck circumference, gender) or the Epworth Sleepiness Scale, which measures daytime sleepiness. These tools screen for risk but cannot confirm the diagnosis on their own (AASM Clinical Practice Guideline for Diagnostic Testing for Adult OSA, 2017).
A diagnosis requires an objective sleep study, which measures the apnea-hypopnea index (AHI) — the average number of apneas plus hypopneas per hour of sleep.
OSA is confirmed and graded by the AHI, using the AASM and International Classification of Sleep Disorders (ICSD-3) framework:
Reports may also note the oxygen desaturation index (ODI) and the lowest oxygen saturation reached overnight, which help describe how much the blood oxygen drops. Definitions of a hypopnea have varied across AASM scoring rules over the years (the airflow-reduction and oxygen-desaturation thresholds differ), which is one reason two tests can report somewhat different AHI values.
Treatment is individualized to severity, anatomy, and patient preference, and usually combines behavioral changes with a device or, in selected cases, medication or surgery. The goals are to keep the airway open during sleep, normalize the AHI and oxygen levels, relieve symptoms, and reduce cardiovascular risk.
These are recommended for all patients and may be sufficient on their own in mild cases:
Continuous positive airway pressure (CPAP) is the first-line and most effective treatment for moderate-to-severe OSA (AASM). A bedside machine delivers a gentle, steady stream of air through a mask, acting as a pneumatic splint that holds the airway open. Variations include auto-adjusting PAP (APAP), which varies pressure through the night, and bilevel PAP (BiPAP), which uses different pressures for breathing in and out and can help people who struggle with standard CPAP. When used consistently, PAP reliably reduces the AHI, daytime sleepiness, and blood pressure; the main limitation is adherence, since some people find the mask uncomfortable.
A custom-fitted mandibular advancement device, made by a dentist trained in sleep medicine, holds the lower jaw and tongue slightly forward to keep the airway open. Oral appliance therapy is a recommended alternative for adults with mild-to-moderate OSA, and for those with more severe disease who cannot tolerate PAP (AASM/American Academy of Dental Sleep Medicine).
For the first time, a medication is FDA-approved specifically for OSA. In December 2024, the FDA approved tirzepatide (Zepbound) — a GLP-1/GIP receptor agonist (the same class as drugs used for weight management) — for moderate-to-severe OSA in adults with obesity, to be used alongside a reduced-calorie diet and increased physical activity. Approval was based on the phase 3 SURMOUNT-OSA trial, in which tirzepatide meaningfully reduced the AHI; nearly half of participants reached a threshold consistent with disease remission or no symptoms (Eli Lilly; AASM). It works indirectly, primarily through weight loss, and is an option for selected patients rather than a universal replacement for PAP.
There is no over-the-counter medication that treats OSA itself. Nasal strips, saline, or decongestants may ease nasal breathing but do not correct airway collapse, and sedating sleep aids can worsen apnea. Treating contributing conditions — for example, thyroid hormone replacement for hypothyroidism — is also part of care.
For patients who cannot tolerate PAP or have correctable anatomy, options include hypoglossal nerve stimulation — an implanted device (such as Inspire) that activates the tongue muscles with each breath to keep the airway open. It is not a first-line therapy; it is reserved for select adults with moderate-to-severe OSA who have not succeeded with PAP, typically within a defined body-mass-index range and after a procedure confirms a suitable airway collapse pattern. Other surgical approaches include tonsillectomy/adenoidectomy (the first-line treatment in children), procedures to reduce or reposition soft-palate and throat tissue, and jaw-advancement surgery in carefully selected cases.
OSA cannot always be prevented — anatomy and age are not modifiable — but its risk and severity can often be reduced, and it can be managed effectively over the long term. Maintaining a healthy weight is the most impactful preventive and management strategy; limiting alcohol and sedatives, not smoking, and treating nasal and allergic problems also help.
For most people, OSA is a chronic condition that requires ongoing management rather than a one-time cure. Long-term success depends heavily on adherence — for example, using PAP nightly or wearing an oral appliance consistently. Sleep clinicians monitor therapy over time using device data, repeat questionnaires, and sometimes follow-up sleep studies, and they adjust the treatment when weight, anatomy, or symptoms change. Because OSA so often travels with high blood pressure, diabetes, and heart rhythm problems, coordinated care that addresses these related conditions is part of good long-term management.
It is worth talking to a clinician — and asking about a sleep evaluation — if you or a bed partner notice:
Seek prompt medical attention for red-flag features, including falling asleep at the wheel or near-miss drowsy-driving episodes, waking gasping for air or with chest pain or palpitations, or new or hard-to-control high blood pressure, an irregular heartbeat such as atrial fibrillation, or symptoms after a stroke or heart event — situations in which untreated OSA can be especially dangerous. Anyone whose sleepiness threatens safe driving should raise this with a clinician without delay.
The outlook for treated OSA is generally good. With consistent therapy, most people experience marked improvements in daytime alertness, mood, concentration, and quality of life, and many see better blood pressure control. Effective treatment also reduces the night-to-night oxygen swings and arousals that strain the heart and blood vessels.
Left untreated, moderate-to-severe OSA is associated with higher risks of hypertension, heart attack, stroke, atrial fibrillation, type 2 diabetes, depression, motor-vehicle and workplace accidents, and reduced quality of life (NIH/StatPearls; American Heart Association). The encouraging message is that OSA is highly treatable: the major challenge is recognizing it and sticking with therapy, not a lack of effective options.
Can you have sleep apnea without snoring? Yes. While loud snoring is the classic sign, some people — particularly women and those with central sleep apnea — have little or no snoring and instead notice fatigue, insomnia, morning headaches, or mood changes. A normal report of "no snoring" does not rule out OSA if other symptoms or risk factors are present.
Is CPAP the only treatment, or are there alternatives? CPAP is the most effective and first-line therapy for moderate-to-severe OSA, but it is not the only option. Alternatives include auto-adjusting or bilevel PAP, custom oral appliances (mandibular advancement devices), weight loss, positional therapy, hypoglossal nerve stimulation, and surgery — plus, for adults with obesity and moderate-to-severe OSA, the medication tirzepatide. The best choice depends on severity, anatomy, and personal preference, so it is worth discussing the full menu with a sleep specialist.
Will losing weight cure my sleep apnea? Weight loss can substantially lower the AHI and sometimes resolves mild OSA, and it is one of the most valuable things many people can do. However, not everyone is cured by weight loss alone — anatomy and other factors matter — so therapy should not be stopped without a clinician's guidance and ideally a repeat sleep study to confirm improvement.
Does using a CPAP machine become a lifelong commitment? For most people, OSA is a chronic condition, and CPAP works only while it is being used — symptoms typically return if therapy stops. That said, treatment can change over time: significant weight loss, surgery, or an oral appliance may reduce or end the need for CPAP in some people. Any change should be guided by a clinician and, when appropriate, confirmed with testing.
Is sleep apnea dangerous if I feel fine during the day? Possibly. Some people with significant OSA do not feel noticeably sleepy, yet the repeated drops in oxygen and arousals still strain the cardiovascular system. Because OSA is linked to hypertension, heart rhythm problems, and stroke risk independent of how sleepy a person feels, treatment is often recommended even when daytime symptoms are mild — a decision best made with a clinician based on AHI, oxygen levels, and overall health.
CPAP (continuous positive airway pressure) is the first-line, evidence-based therapy for moderate-to-severe OSA. Other FDA-cleared/approved options include custom oral appliances (mandibular advancement devices) for mild-to-moderate disease or CPAP intolerance, and hypoglossal nerve stimulation (Inspire), first FDA-approved in 2014, for select adults who cannot tolerate CPAP; a 2017 expansion broadened the eligible AHI range to 15 to 65. In December 2024 the FDA approved tirzepatide (Zepbound) as the first prescription medication for moderate-to-severe OSA in adults with obesity, used alongside a reduced-calorie diet and increased physical activity; in the SURMOUNT-OSA trials it reduced breathing events by about 25 to 29 per hour, with roughly 43% and 51.5% of participants meeting disease-resolution criteria at the highest dose. Treatment choice should be individualized with a qualified clinician; this is informational only and not medical advice.
Obstructive sleep apnea is caused by the soft tissues at the back of the throat relaxing and blocking the upper airway during sleep, which repeatedly interrupts breathing. Common contributing factors include excess weight, a narrow airway, large tonsils, a recessed or small jaw, nasal congestion, older age, and a family history of the condition. Alcohol, sedatives, and sleeping on your back can make airway collapse worse. A clinician can help identify which factors apply to you.
The most common signs are loud, chronic snoring, gasping or choking awakenings, and witnessed pauses in breathing during sleep, often noticed by a bed partner. Daytime symptoms include excessive sleepiness, fatigue, morning headaches, difficulty concentrating, irritability, and mood changes. Because some people have few obvious symptoms, talk to a clinician if you snore heavily or feel persistently tired despite enough sleep.
Obstructive sleep apnea is diagnosed with a sleep study, either an in-lab polysomnography test or a home sleep apnea test, which measures breathing, oxygen levels, and disruptions. The key metric is the apnea-hypopnea index (AHI), the number of breathing interruptions per hour: an AHI of 5 to 14 indicates mild, 15 to 29 moderate, and 30 or more severe sleep apnea. Only a qualified clinician can interpret these results and confirm a diagnosis.
For most adults, obstructive sleep apnea is a chronic condition that can be effectively managed but not reliably cured. In some cases, significant weight loss or surgery to correct a specific anatomical cause can eliminate or greatly reduce symptoms, but the condition can return if weight is regained or over time, so follow-up sleep testing is often needed to confirm improvement. Treatments such as CPAP and oral appliances control the condition only while they are being used rather than curing it. Discuss realistic goals with a sleep specialist.
CPAP (continuous positive airway pressure) is the most established and effective treatment, using gentle air pressure to keep the airway open during sleep. Other options include oral appliances that reposition the jaw, weight management, positional therapy to avoid back sleeping, hypoglossal nerve stimulation devices, and surgery when there is a clear anatomical cause. The best choice depends on severity and individual factors, so treatment should be guided by a clinician.
Untreated obstructive sleep apnea is linked to a higher risk of high blood pressure, heart disease, irregular heart rhythms, heart failure, stroke, and type 2 diabetes, and the risk tends to rise with severity. The repeated drops in oxygen and disrupted sleep also contribute to daytime fatigue, mood problems, reduced concentration, and a greater risk of motor vehicle and workplace accidents. Because these risks are serious, anyone who suspects sleep apnea should seek medical evaluation.
No, snoring and sleep apnea are not the same, though they often overlap. Snoring is noisy breathing caused by vibrating throat tissue, while obstructive sleep apnea involves actual pauses in breathing along with drops in blood oxygen. Many people with sleep apnea snore, but not all snorers have apnea; warning signs that point toward apnea include gasping or choking, witnessed breathing pauses, and daytime sleepiness. A sleep study is the only way to tell them apart with certainty.
Yes, weight loss can meaningfully improve obstructive sleep apnea for people who carry excess weight, since fat around the neck and upper airway contributes to airway collapse. Studies show that losing even around 10 percent of body weight can reduce the number and severity of breathing events, and some people are able to reduce or stop CPAP after substantial weight loss. However, weight loss does not always fully resolve the condition and improvements can reverse if weight is regained, so changes should be monitored by a clinician with repeat sleep testing.
Independent, evidence-based reviews — not paid placements. See our full analysis:
This page is for general information and is not medical advice. Always consult a qualified clinician about diagnosis and treatment. Individual results vary.